Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and Li-Fraumeni Syndrome

lapatinib has been researched along with Li-Fraumeni Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arribas, J; Baselga, J; Caratù, G; De Mattos-Arruda, L; Felip, E; Grueso, J; Hernández-Losa, J; Nuciforo, P; Parra, JL; Prudkin, L; Puente, XS; Scaltriti, M; Seoane, J; Serra, V; Silberschmidt, D; Vivancos, A1

Other Studies

1 other study(ies) available for lapatinib and Li-Fraumeni Syndrome

ArticleYear
Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation.
    Cancer discovery, 2013, Volume: 3, Issue:11

    Topics: Adult; Exome; Female; Humans; Lapatinib; Li-Fraumeni Syndrome; Mutation; Neoplasm Metastasis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Signal Transduction; Tumor Cells, Cultured

2013